FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Co-Diagnostics Gains CE Mark for ZDC Multiplex Test

March 8, 2019
A A

Co-Diagnostics received the CE Mark for its Logix Smart Zika/Dengue/Chikungunya in vitro diagnostic test and the company is now producing the multiplex test at its facility in Salt Lake City, Utah.

The Logix Smart test detects the three mosquito-transmitted viruses in patients and distinguishes between them by analyzing their RNA. If a specimen tests positive for Zika, a cerebral spinal fluid sample can be taken to look for neurological infection.

Zika, dengue and chikungunya all have similar symptoms — such as joint pain and severe fever — and can be misdiagnosed by physicians.

View today's stories